Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-Making
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Development of an Intelligent System Integrating Preoperative Imaging and Real-Time Intraoperative Metabolic Feedback to Dynamically Optimize Biopsy core Placement for Individualized Precision Sampling.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 55 lat lub więcej
- •Wskazanie do biopsji prostaty
- •Wyniki badań (PSA, wolne PSA, rezonans magnetyczny prostaty) dostępne maksymalnie miesiąc przed biopsją
✗ Disqualifies
- •Zdiagnozowany inny nowotwór złośliwy niż rak prostaty
- •Inne nowotwory, które mogą wpłynąć na wyniki obrazowania (np. rak odbytnicy, pęcherza, jąder)
- •Ważne problemy zdrowotne, takie jak wyniszczenie organizmu lub niewydolność narządów
Simplified criteria — AI translation
Trial details
- Minimum age
- 55 Years
- Last updated (source)
- October 2, 2026
- Sex
- Male only
Locations (4)
Minhang Hospital, Fudan University
Shanghai, China
Shanghai Geriatric Medical Center
Shanghai, China
Xuhui Hospital, Fudan University
Shanghai, China
Zhongshan Hospital, Fudan University
Shanghai, China
Trial contact
Minhang Hospital, Fudan University
Shanghai Geriatric Medical Center
Xuhui Hospital, Fudan University
Zhongshan Hospital, Fudan University
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/3/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.